1-(3-Fluorophenyl)-2-hydroxyethan-1-one, 98%, 250mg

(2S,3S,4R,5R,6R)-6-(Acetoxymethyl)-3-hydroxytetrahydro-2H-pyran-2,4,5-triyl triacetate, 95.0%, 5g

4-(3-Bromo-4-fluorophenyl)-3-(4-nitro-1,2,5-oxadiazol-3-yl)-1,2,4-oxadiazol-5(4H)-one, 98%, 5g

N-(3,4-Dimethylphenyl)-4-methylbenzenesulfonamide, 95%, 500mg

Narrow mouth bottle ROTILABO® aluminium, 60 ml, 10 Piece(s)

7-Methyl-2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-sulfonyl chloride, 5g

Methyl 3-hydroxybicyclo[1.1.1]pentane-1-carboxylate, 98%, 10g

2-Cyclopentaneethanol>98.0%(GC)5mL

[3-(propan-2-yl)oxetan-3-yl]methanol, 97.0%, 1g

Methyl 3-{[3-(trifluoromethyl)benzyl]oxy}-2-thiophenecarboxylate, 1g

2-Iodo-3-methylthiophene, 98%, 25g

Sertraline Hydrochloride>98.0%(HPLC)(T)5g

1-(3-fluorophenyl)-3-(propan-2-yl)-4,5-dihydro-1H-pyrazol-5-one, 95.0%, 2g